Liang Zhang
Lawyers
Filters
Charles River Laboratories acquisition of Vigene Biosciences
We are advising Charles River on the acquisition
BCPE Empire Topco $660 million senior notes offering
We advised the initial purchasers on the high-yield notes offering
EnVen Energy $300 million high-yield notes offering and credit facility amendment
We advised EnVen on its senior secured notes offering and credit facility
Ford Motor Company $2.3 billion convertible senior notes offering
We advised Ford on the Rule 144A offering
Masco $1.5 billion notes offering
We advised the underwriters on the investment-grade debt offering
Charles River Laboratories $875 million acquisition of Cognate
We advised Charles River on the acquisition of a cell and gene therapy contract development and manufacturing organization
Murphy USA $1.25 billion financing
We advised Murphy on a $500 million high-yield notes offering and $750 million in credit facilities
MercadoLibre $1.1 billion inaugural registered notes offering
The investment-grade offering included the company’s first sustainability notes
MicroStrategy $650 million convertible senior notes offering
Davis Polk advised the initial purchaser in connection with a Rule 144A offering by MicroStrategy Incorporated of $650 million aggregate principal amount of its 0.750% convertible…
CSX $500 million notes offering
Davis Polk advised CSX Corporation on its SEC-registered offering of $500 million aggregate principal amount of 2.500% senior notes due 2051.
CSX, based in Jacksonville, Florida, is a…